What to Expect From ResMed's Next Quarterly Earnings Report

San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders. Valued at a market cap of $41.1 billion, the company is scheduled to announce its fiscal Q1 earnings for 2026 in the near future. Before this event, analysts expect this healthcare company to report a profit of $2.49 per share, up 13.2% from $2.20 per share in the year-ago quarter. The company has a promis ...